| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |